Feds sign $18M vaccine IT deal; Investors back Riffyn to make R&D reproducible;

> The FDA and the CDC awarded an $18 million contract for the Vaccine Adverse Event Reporting System. Article

> Riffyn raised $1.8 million to develop software that increases the reproducibility of R&D. Piece

> More than two-thirds of Big Pharma outsource the collection of data for research initiatives. Post

> UK Trade & Investment created a database and interactive map of the 5,000 life science companies and sites in its jurisdiction. Article

> Lab7 expanded its library of open source bioinformatics tools, BioBuilds. Release

> YPrime released a new version of its interactive response technology. News

> The Cambridge Crystallographic Data Centre struck deals for its system with 11 countries. Item

> Merge eClinical signed a deal that will see its eClinicalOS used to run a trial in India for the first time. Post

> GoBalto released a reporting tool for its clinical trial management package. News

> TransCelerate BioPharma published more evidence the traditional model of source data verification is inefficient. News

> PatientsLikeMe began a campaign to encourage people to share their health data. Release

> MIT Technology Review looked at the sequencing operation Regeneron ($REGN) is building. Feature

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.